CAS: 301692-76-2 - 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
Formula:C18H16FNO4S
InChI:InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)
InChI key:InChIKey=IJWPAFMIFNSIGD-UHFFFAOYSA-N
SMILES:O=C1C(C2=CC=CC(F)=C2)=C(OC1(C)C)C=3C=CC(=CC3)S(=O)(=O)N
4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
CAS:301692-76-2
Formula:
C18H16FNO4S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
361.3873
Ref: IN-DA00C40H
25mg | 192.00 € | ||
50mg | 324.00 € | ||
100mg | 519.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Polmacoxib
CAS:301692-76-2
Formula:
C18H16FNO4S
Color and Shape:
Pale Yellow Solid
Molecular weight:
361.39
Ref: 4Z-P-279001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Polmacoxib
CAS:301692-76-2
Polmacoxib, a first-class NSAID, dual inhibitor of CA and COX-2, may hinder colorectal cancer growth …
Formula:
C18H16FNO4S
Purity:
98.49%
Color and Shape:
Solid
Molecular weight:
361.39
Ref: TM-T21294
2mg | 46.00 € | ||
5mg | 70.00 € | ||
10mg | 106.00 € | ||
25mg | 172.00 € | ||
50mg | 256.00 € | ||
100mg | 373.00 € | ||
200mg | 554.00 € | ||
1mL*10mM (DMSO) | 76.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Polmacoxib
CAS:301692-76-2
Polmacoxib is a cox-2 inhibitor that binds to the enzyme cyclooxygenase-2 (COX-2), preventing the formation …
Formula:
C18H16FNO4S
Purity:
Min. 95%
Color and Shape:
Light (Or Pale) Yellow To Yellow Solid
Molecular weight:
361.07841
Ref: 3D-FP172578
2mg | 136.00 € | ||
5mg | 217.00 € | ||
10mg | 346.00 € | ||
25mg | 542.00 € | ||
50mg | 775.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Polmacoxib
Controlled ProductCAS:301692-76-2
Formula:
C18H16FNO4S
Color and Shape:
Neat
Molecular weight:
361.387
Ref: TR-P698950
250mg | 10,915.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025